Active, not recruitingNCT07448480

Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas

Studying Anaplastic astrocytoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Blokhin's Russian Cancer Research Center
Principal Investigator
David Naskhletashvili, MD, PhD
N.N. Blokhin National Medical Research Center of Oncology
Intervention
Bevacizumab-Containing Regimens(drug)
Enrollment
1000 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07448480 on ClinicalTrials.gov

Other trials for Anaplastic astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Anaplastic astrocytoma →

← Back to all trials